Single-Center Experience with Ifosfamide Monotherapy as Second-Line Treatment of Recurrent/Metastatic Osteosarcoma. [electronic resource]
- The oncologist 04 2020
- e716-e721 p. digital
Publication Type: Journal Article
1549-490X
10.1634/theoncologist.2019-0528 doi
Antineoplastic Combined Chemotherapy Protocols Bone Neoplasms--drug therapy Humans Ifosfamide--therapeutic use Neoplasm Recurrence, Local--drug therapy Osteosarcoma--drug therapy Retrospective Studies Treatment Outcome